financetom
Personal Finance
financetom
/
Personal Finance
/
Here's how health insurance policies will change from today
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Here's how health insurance policies will change from today
Sep 30, 2020 12:02 PM

A lot of changes kick in the health insurance sector from today to help consumers in buying insurance, in a way making it easier to understand the terms and conditions.

Live TV

Loading...

According to Pankaj Arora, managing director and chief executive officer, Raheja QBE General Insurance, the general and health insurance industry is keeping pace with the advancement in technologies that are taking place in the health care industry.

"With the increase in the number of health insurance products in the market, it has been desired that the industry adopts a uniform approach while incorporating exclusions in the health insurance products," he opines.

The new guidelines require insurance companies to make three major changes in their policies:

Standardization of products

Health insurance products will become more inclusive, less complicated, and more attractive to customers from October 1 by incorporating these amendments:

Coverage for uncovered ailments

According to IRDAI’s guideline, insurance companies cannot exclude diseases like mental illness, stress or psychological disorder, illness contracted due to hazardous activity, treatment like age-related disorder, internal congenital disease, genetic disease, or disorder.

Hence, coverage for these diseases which are excluded or are not covered in health insurance products so far will be covered from October 2020 by all insurance companies.

New pre-existing disease (PED) Definition

The definition of pre-existing disease (PED) is being modified to cater to the needs and requirements of customers.

In accordance with the issued guidelines, any disease/s or ailment/s that is/are diagnosed by a physician 48 months before the issuance of the health cover will be classified under PED. Also, any disease/s or ailment/s for which any type of medical advice or treatment was recommended by a qualified doctor 48 months before the issuance of the policy will also be qualified under PED, according to Arora.

Further, any condition whose symptoms or signs have resulted within three months of the issuance of the policy will also be classified under PED.

"To ensure that policyholders suffering from pre-existing diseases get adequate health insurance coverage, IRDAI has mandated that insurers include permanent exclusions only after due consent of the customers. Apart from a list issued by the IRDAI, no other exclusions will be allowed in the health insurance plans," explains Arora.

Coverage for mordent treatments and advancement in Technologies

Insurance companies will not be able to deny health insurance coverage to modern treatment methods like Robotic Surgeries, Uterine Artery Embolization and HIFU, Balloon Sinuplasty, Deep brain stimulation, Oral Chemotherapy, Intravitreal injection, etc, however, they can put the sub-limits for the mention coverages.

Moratorium period

Insurance companies cannot reject a claim after completion of eight years of continuous coverage except for proven frauds and permanent exclusions.

Shorter waiting period for lifestyle disease

Waiting period for lifestyle diseases like diabetes, hypertension, cardiac condition will be allowed only up to 90 days.

Coverage for oral chemotherapy and peritoneal dialysis

Insurance companies cannot deny claims for oral chemotherapy where chemo is covered and peritoneal dialysis where dialysis is covered subject to product design.

"Standardisation of health will make things easier for customers and will provide clarity on what the health insurance company is covering under the chosen plan. With this in mind, it will be easier for customers to compare and get the most suited plan for themselves. This might lead to a slight price increase in the health insurance plans, but overall it is a good move for the customer," says Naval Goel, CEO, PolicyX.

Ensuring insurance coverage for telemedicine

Telemedicine would be liable to get the required coverage under health insurance wherever medical consultation is allowed. Usually plans with OPD covers would benefit under these guidelines.

Given the current situation, teleconsultation is likely to replace physical consultation in a big way.

"It is a win-win for both customers as well as companies as customers will be able to get this facility and companies will be able to save some cost as teleconsultation is much cheaper compared to physical consultation and also services can be standardised and controlled," opines Goel.

First Published:Sept 30, 2020 9:02 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Downgrades Opinion On Shares Of Skyworks Solutions To Sell From Hold
Research Alert: CFRA Downgrades Opinion On Shares Of Skyworks Solutions To Sell From Hold
May 5, 2026
01:40 AM EDT, 05/06/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our 12-month target price at $66, on P/E of 12x our CY 27 EPS view of $5.50, near historical forward averages. After better than feared Mar-Q results/Jun-Q guide,...
Research Alert: CFRA Keeps Sell Opinion On Ads Of Fresenius Medical Care
Research Alert: CFRA Keeps Sell Opinion On Ads Of Fresenius Medical Care
May 5, 2026
12:55 AM EDT, 05/06/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We adjust our target price to USD19 from USD21, implying 8.2x of our 2026 EPADS, below its three-year historical forward P/E of 12.9x to reflect the long-term growth uncertainty on...
Research Alert: CFRA Downgrades Opinion On Shares Of Qorvo To Sell From Hold
Research Alert: CFRA Downgrades Opinion On Shares Of Qorvo To Sell From Hold
May 5, 2026
01:35 AM EDT, 05/06/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We increase our 12-month target to $89 from $81, on a P/E of about 11.5x our CY 27 EPS view of $7.76, below historical to reflect challenges across the RF...
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Advanced Micro Devices
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Advanced Micro Devices
May 6, 2026
07:20 AM EDT, 05/06/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our target to $500 from $400, based on a P/E of 29.4x our 2028 EPS view, above peers/below historical. We lift our EPS to $7.22 from $6.71 for...
Copyright 2023-2026 - www.financetom.com All Rights Reserved